✦Canada Post Xpress1–2 day delivery across CanadaFree on orders over $200
Your cart is empty
Janoshik
Batch TBBP-CA-26E-01
Recovery Compound
Also known as Wolverine Blend
BPC-157 – TB-500 Blend is a combination of two research peptides studied in laboratory settings for their potential roles in cellular signaling related to tissue repair, inflammation modulation, and recovery pathways. The combination is often explored for its complementary activity in peptide signaling studies.
This product is intended strictly for laboratory research use within Canada. It is not approved by Health Canada for the diagnosis, treatment, cure, or prevention of any disease. Not for human or veterinary use.
By purchasing, you confirm the material will be used solely for lawful research purposes in accordance with applicable Canadian regulations.
BPC-157 – TB-500 Blend, also known as the Wolverine Blend, is a dual-peptide research formulation combining BPC-157 and TB-500 in equal concentrations.
In scientific literature, BPC-157 is described as a synthetic fragment derived from a gastric protein sequence, while TB-500 is a synthetic form of thymosin beta-4. Together, they are studied in experimental models examining cellular response pathways, angiogenic signaling systems, and cytoskeletal dynamics under in vitro and preclinical research conditions.
Third-party tested for purity, ID, quantity.
BPC-157 and TB-500 have been independently examined in preclinical research environments. BPC-157 has been studied in models involving angiogenic signaling and connective tissue frameworks, while TB-500 has been evaluated in structural pathway and cellular migration research systems.
Within laboratory settings, the combined formulation is explored in experimental systems assessing coordinated peptide interaction across structural signaling pathways and cytoskeletal dynamics.
BPC-157 emerged from gastric peptide research in the early 1990s, while TB-500 research developed from investigations into thymosin beta-4 and its role in structural and cellular signaling pathways.
The BPC-157 – TB-500 Blend represents a research-based integration of these peptides into a unified formulation for controlled experimental study.
Laboratory investigations involving BPC-157 and TB-500 have explored structural pathway signaling, angiogenic models, and cellular migration frameworks. Experimental research examines peptide interaction within connective tissue systems and multi-pathway signaling environments under controlled in vitro and preclinical conditions.
No. Eppix Labs products are supplied exclusively for laboratory research. We do not provide dosing, administration, or usage guidance.
Each vial contains 10mg of BPC-157 and 10mg of TB-500, totaling 20mg of lyophilized peptide blend. Independent third-party testing verifies purity, identity, and batch composition.
The vial contains only the lyophilized peptide blend. Any laboratory materials required for experimental procedures must be sourced separately.
Duration depends entirely on research protocol, storage conditions, and laboratory application.
Gastric pentadecapeptide BPC 157 accelerates healing of transected rat Achilles tendon and in vitro stimulates tendocytes growth.
PubMedThe promoting effect of pentadecapeptide BPC 157 on tendon healing involves tendon outgrowth, cell survival, and cell migration. J Appl Physiol (1985) 110(3):774–780.
PubMedFocus on ulcerative colitis: stable gastric pentadecapeptide BPC 157. Curr Med Chem 19(1):126–132.
PubMedThymosin beta4 induces adult epicardial progenitor mobilization and neovascularization.
PubMedRelated
Studied in metabolic research for its effects on glucose regulation, appetite signaling, and energy balance.
From$180.00
Dual incretin receptor agonist studied for glucose regulation, metabolic signaling, and weight pathway research
From$10.00
Immune-modulating peptide studied for T-cell signaling and immune system regulatory pathway research
From$70.00
GHRH analog studied for growth hormone regulation and metabolic pathway signaling research
From$95.00
